ARS Investment Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-32,400
Closed -$154K 153
2020
Q4
$154K Buy
+32,400
New +$167K 0.02% 122
2020
Q3
Sell
-25,746
Closed -$84K 118
2020
Q2
$84K Sell
25,746
-203,691
-89% -$1.93M 0.02% 73
2020
Q1
$1.18M Sell
229,437
-103,489
-31% -$419K 0.28% 51
2019
Q4
$1.52M Sell
332,926
-126,615
-28% -$617K 0.26% 63
2019
Q3
$2.81M Sell
459,541
-62,286
-12% -$371K 0.51% 46
2019
Q2
$3.18M Buy
521,827
+20,621
+4% +$139K 0.53% 45
2019
Q1
$2.78M Sell
501,206
-151,678
-23% -$985K 0.5% 42
2018
Q4
$3.69M Sell
652,884
-224,740
-26% -$1.66M 0.78% 31
2018
Q3
$9.21M Buy
877,624
+81,257
+10% +$872K 1.43% 23
2018
Q2
$8.84M Sell
796,367
-63,635
-7% -$572K 1.41% 26
2018
Q1
$6.88M Sell
860,002
-12,967
-1% -$104K 0.84% 40
2017
Q4
$7.16M Buy
872,969
+87,626
+11% +$593K 0.87% 34
2017
Q3
$4.87M Buy
785,343
+113,662
+17% +$699K 0.63% 44
2017
Q2
$4.06M Buy
671,681
+152,686
+29% +$954K 0.56% 49
2017
Q1
$2.75M Sell
518,995
-101,941
-16% -$594K 0.4% 57
2016
Q4
$4.22M Buy
+620,936
New +$4.3M 0.65% 49

Other funds holding CEMI

ARS Investment Partners's CEMI Position: Q1 2021 in Review

ARS Investment Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2021, closing a stake of 32,400 shares — an estimated $154K sold.

ARS Investment Partners first reported a position in CEMI in Q4 2016 and held it in 16 quarters. The position peaked at $9.21M in Q3 2018. 72 funds tracked by Wall St. Rank hold CEMI as of Q1 2021.

  • ARS Investment Partners reported no remaining Chembio diagnostics, Inc. position as of Q1 2021 after selling out during the quarter.
  • ARS Investment Partners sold 32,400 Chembio diagnostics, Inc. shares in Q1 2021, an estimated $154K.
  • ARS Investment Partners first reported a position in Chembio diagnostics, Inc. in Q4 2016 and held it in 16 quarters.
  • ARS Investment Partners's Chembio diagnostics, Inc. position peaked at $9.21M in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2021.

Based on ARS Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.